ArticleDrugs - real world outcomes2024

Economic Burden of Parkinson's Disease: A Multinational, Real-World, Cost-of-Illness Study.

K Ray Chaudhuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.